Simple home walks may ease dialysis symptoms, small trial hopes to prove
NCT ID NCT07272070
First seen Jun 26, 2026 · Last updated Sep 01, 2026 · Updated 5 times
Summary
This study tests whether walking at home for 30 minutes, 5 days a week, can reduce symptoms like muscle cramps and improve overall health in people on hemodialysis. Twenty-four adults who can walk independently and own a smartphone will be tracked for 8 weeks. The goal is to see if this easy, low-cost exercise can make daily life better for dialysis patients.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- home-based moderate-speed walking
- What this could lead to
- If it works, this could offer a simple, low-cost way to reduce symptoms like muscle cramps and improve quality of life for people on dialysis.
- What could go wrong
- This is a very small early trial with only 24 participants, so results may not apply to everyone. Walking may not significantly change symptoms or health outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 24 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2025
- Expected to finish
-
Aug 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients who agreed to participate in the research during the data collection process, * Over 18 years of age, * Speak and understand Turkish, * Are at least literate, * Can perform daily living activities independently, * Own a smartphone. Exclusion Criteria: * Do not have sufficient cognitive ability, * Have arthritic or orthopedic problems requiring assistance with walking, * Have significant visual or hearing impairments, * Walk regularly, * Have a hemoglobin level \<8 mg/dl, * Have Stage IV of New York heart failure.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hemodialysis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ankara Bilkent City Hospital
Ankara, Çankaya, 06800, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Muscle disease may confuse heart attack tests: study aims to clarify
- Can a chatbot keep dialysis patients on track between sessions?
- Can a health worker at your dialysis clinic keep you out of the hospital?
- Can mindfulness calm the mind and improve sleep for dialysis patients?
- Can a simple relaxation technique calm night pain in dialysis?
- Can a breathing device make dialysis patients stronger?